Management of Helicobacter pylori infection is evolving and in this 4th edition of the
Maastricht consensus report aspects related to the clinical role of H pylori were looked at …

Abstract Background and Aims. Prevalence of H. pylori antibiotic resistance is increasing
worldwide, and it is the main factor affecting efficacy of current therapeutic regimens. Our …

Background Helicobacter pylori is associated with benign and malignant diseases of the
upper gastrointestinal tract, and increasing antibiotic resistance has made alternative …

Helicobacter pylori, a gram-negative microaerophilic pathogen, causes several upper
gastrointestinal diseases, such as chronic gastritis, peptic ulcer disease, and gastric cancer …

Helicobacter pylori antibiotic resistance is a serious concern in China, where it severely
influences treatment for H. pylori infection. To overcome this, it is essential to apply …

Abstract Knowledge on the role of Helicobacter pylori (HP) infection is continually evolving,
and treatment is becoming more challenging due to increasing bacterial resistance. Since …

The gram-negative bacterium Helicobacter pylori (H. pylori) causes chronic gastritis, gastric
and duodenal ulcers, gastric cancer and mucosa-associated lymphoid tissue lymphoma …

Despite the declining trend of Helicobacter pylori (H. pylori) prevalence around the globe,
ongoing efforts are still needed to optimize current and future regimens in view of the …

Основное содержание. Терапией первой линии для эрадикации инфекции H. pylori
служит стан дартная тройная терапия, включающая ингибитор протонной помпы …

It is accepted that the success of Helicobacter pylori eradication treatment using standard
triple therapy is declining. Resistance, particularly to clarithromycin, has been shown in …